Sigma Labs, Inc. Logo

Sigma Labs, Inc.

SGLB

(0.8)
Stock Price

1,05 USD

-367.88% ROA

-99.87% ROE

-0.4x PER

Market Cap.

3.886.185,00 USD

0% DER

0% Yield

-911.91% NPM

Sigma Labs, Inc. Stock Analysis

Sigma Labs, Inc. Fundamental Analysis

Fundamental analysis in stock investing is like studying the foundation of a house before buying it. It involves looking at a company's financial health, like its earnings, assets, and debts, to determine if it's a good investment based on its fundamental strength and potential for growth.

Sigma Labs, Inc. Fundamental Stock Analysis
# Analysis Rating
1 DER

The stock has a minimal amount of debt (0%) relative to its ownership, showcasing a strong financial position and lower risk for investors.

2 Graham Number

The Graham number calculation reveals that this company's stock price is potentially underestimated, implying that it may be a promising investment option.

3 ROE

Negative ROE (-163.15%) indicates poor financial performance, raising concerns about profitability and efficiency in utilizing shareholders' equity.

4 ROA

The stock's ROA (-423.41%) suggests that it's struggling to generate profits from its assets, making it a risky choice for investment.

5 PBV

The stock's high Price-to-Book Value (P/BV) ratio (13.65x) suggests it's overvalued, potentially making it an expensive investment.

6 Revenue Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

7 Net Profit Growth

Despite the passage of five years, this company's net profit has not shown any improvement, highlighting a lack of growth and making it a less appealing investment prospect.

8 Assets Growth

Company has experienced no growth in revenue over the past three years, suggesting limited profitability and making it a less desirable investment opportunity.

9 Dividend Growth

Potential investors should be aware that the company's dividend growth has shown no upward trend in the past three years, indicating limited potential for increased returns.

10 Dividend

The company has not distributed any dividends in the past three years, which may raise concerns for investors looking for regular income from their investments.

11 Buffet Intrinsic Value

Warren Buffett's formula suggests that the company's stock is overpriced (0), presenting a possible disadvantage for investors as its market price surpasses its estimated intrinsic value.

Sigma Labs, Inc. Technical Analysis

Technical analysis in stock investing is like reading the patterns on a weather map to predict future weather conditions. It involves studying past stock price movements and trading volumes to make predictions about where a stock's price might go next, without necessarily looking at the company's financial health.

Sigma Labs, Inc. Technical Stock Analysis
# Analysis Recommendation

Sigma Labs, Inc. Price Chart

Financial Statements

Financial statements are like report cards for companies. They show how much money a company makes (income statement), what it owns and owes (balance sheet), and where it spends its money (cash flow statement), helping stock investors understand if a company is healthy and worth investing in.

Income Statements

An income statement for a company is like a scoreboard for its profits and losses. It shows how much money the company made (revenue) and how much it spent to make that money (expenses), helping stock investors see if a company is making a profit or not.

Revenue in stock investing is the total amount of money a company earns from its sales, and it's a key factor that investors consider to assess a company's financial performance and growth potential.

Sigma Labs, Inc. Revenue
Year Revenue Growth
2001 1.267
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 498.504 100%
2011 797.354 37.48%
2012 986.499 19.17%
2013 1.071.439 7.93%
2014 548.723 -95.26%
2015 1.234.810 55.56%
2016 966.422 -27.77%
2017 641.049 -50.76%
2018 388.574 -64.97%
2019 402.446 3.45%
2020 807.488 50.16%
2021 1.651.765 51.11%
2022 630.428 -162.01%
2023 567.952 -11%

Research and Development Expenses are the costs a company incurs to create and improve its products or services, which can be important for investors to evaluate a company's innovation and potential for future growth.

Sigma Labs, Inc. Research and Development Expenses
Year Research and Development Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 0 0%
2013 14.275 100%
2014 219.132 93.49%
2015 330.554 33.71%
2016 92.992 -255.46%
2017 302.043 69.21%
2018 493.410 38.78%
2019 647.994 23.86%
2020 351.404 -84.4%
2021 890.553 60.54%
2022 653.194 -36.34%
2023 980 -66552.45%

General and Administrative Expenses are the costs a company incurs to run its day-to-day operations, such as office rent, salaries, and utilities, which investors consider to understand a company's overall efficiency and management effectiveness.

Sigma Labs, Inc. General and Administrative Expenses
Year General and Administrative Expenses Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 8.984 100%
2010 801.387 98.88%
2011 1.296.200 38.17%
2012 1.117.668 -15.97%
2013 1.230.242 9.15%
2014 2.006.866 38.7%
2015 2.387.096 15.93%
2016 3.158.494 24.42%
2017 3.783.691 16.52%
2018 4.866.660 22.25%
2019 4.508.851 -7.94%
2020 4.311.726 -4.57%
2021 7.002.739 38.43%
2022 7.173.775 2.38%
2023 2.741.256 -161.7%

EBITDA stands for Earnings Before Interest, Taxes, Depreciation, and Amortization. It is a measure that helps stock investors analyze a company's profitability by looking at its earnings without considering certain expenses. This helps to get a clearer picture of the company's financial performance and its ability to generate cash flow.

Sigma Labs, Inc. EBITDA
Year EBITDA Growth
2001 -5.983
2002 -5.366 -11.5%
2003 -5.955 9.89%
2004 -6.504 8.44%
2005 -6.192 -5.04%
2006 -5.753 -7.63%
2007 -6.073 5.27%
2008 -6.457 5.95%
2009 -8.984 28.13%
2010 -401.007 97.76%
2011 -888.844 54.88%
2012 -575.275 -54.51%
2013 -546.677 -5.23%
2014 -552.878 1.12%
2015 -1.696.844 67.42%
2016 -2.920.313 41.9%
2017 -4.018.652 27.33%
2018 -5.341.252 24.76%
2019 -6.112.216 12.61%
2020 -5.079.178 -20.34%
2021 -7.278.973 30.22%
2022 -8.552.722 14.89%
2023 -3.375.472 -153.38%

Gross profit is the money a company makes from selling its products or services after subtracting the cost of producing or providing them, and it is an important measure for investors to understand a company's profitability.

Sigma Labs, Inc. Gross Profit
Year Gross Profit Growth
2001 1.267
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 391.441 100%
2011 384.958 -1.68%
2012 431.671 10.82%
2013 582.812 25.93%
2014 389.787 -49.52%
2015 1.020.806 61.82%
2016 737.520 -38.41%
2017 368.677 -100.05%
2018 118.467 -211.21%
2019 -171.855 168.93%
2020 215.531 179.74%
2021 1.091.800 80.26%
2022 280.498 -289.24%
2023 -136.512 305.47%

Net income in stock investing is like the money a company actually gets to keep as profit after paying all its bills, and it's an important measure to understand how well a company is doing financially.

Sigma Labs, Inc. Net Profit
Year Net Profit Growth
2001 -5.983
2002 -5.366 -11.5%
2003 -5.955 9.89%
2004 -6.504 8.44%
2005 -6.192 -5.04%
2006 -6.317 1.98%
2007 -6.916 8.66%
2008 -7.642 9.5%
2009 -10.184 24.96%
2010 -421.946 97.59%
2011 -910.129 53.64%
2012 -685.566 -32.76%
2013 -734.117 6.61%
2014 -3.116.080 76.44%
2015 -1.696.282 -83.7%
2016 -2.196.834 22.79%
2017 -4.577.516 52.01%
2018 -5.574.163 17.88%
2019 -6.337.797 12.05%
2020 -5.575.747 -13.67%
2021 -8.488.310 34.31%
2022 -8.628.499 1.62%
2023 -3.486.644 -147.47%

EPS, or earnings per share, is a measure that shows how much profit a company has earned for each outstanding share of its stock, and it is important for stock investors as it helps understand the profitability of a company and compare it with other companies in the market.

Sigma Labs, Inc. Earning per Share (EPS)
Year Earning per Share (EPS) Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 0 0%
2012 -64 100%
2013 -60 -8.47%
2014 -204 71.08%
2015 -109 -88.89%
2016 -141 22.86%
2017 -208 32.37%
2018 -162 -28.57%
2019 -108 -50.47%
2020 -29 -268.97%
2021 -17 -70.59%
2022 -16 -6.25%
2023 -6 -166.67%

Cashflow Statements

Cashflow statements show the movement of money in and out of a company, helping stock investors understand how much money a company makes and spends. By examining cashflow statements, investors can assess if a company is generating enough cash to pay its bills, invest in growth, and provide returns to stockholders.

Free cash flow is the leftover cash that a company generates after covering its operating expenses and capital expenditures, which is important for stock investors as it shows how much money a company has available to invest in growth, pay dividends, or reduce debt.

Sigma Labs, Inc. Free Cashflow
Year Free Cashflow Growth
2001 -3.783
2002 -37 -10124.32%
2003 -50 26%
2004 -5.030 99.01%
2005 -9.265 45.71%
2006 -1.856 -399.19%
2007 -3.239 42.7%
2008 -4.352 25.57%
2009 -250 -1640.8%
2010 -528.236 99.95%
2011 -597.533 11.6%
2012 -503.384 -18.7%
2013 -338.456 -48.73%
2014 -1.728.170 80.42%
2015 -1.412.260 -22.37%
2016 -2.050.140 31.11%
2017 -2.931.866 30.07%
2018 -3.991.496 26.55%
2019 -5.722.516 30.25%
2020 -5.108.727 -12.01%
2021 -6.658.709 23.28%
2022 -8.601.116 22.58%
2023 -212.395 -3949.58%

Operating cash flow represents the cash generated or consumed by a company's day-to-day operations, excluding external investing or financing activities, and is crucial for stock investors as it shows how much cash a company is generating from its core business operations.

Sigma Labs, Inc. Operating Cashflow
Year Operating Cashflow Growth
2001 -3.783
2002 -37 -10124.32%
2003 -50 26%
2004 -5.030 99.01%
2005 -9.265 45.71%
2006 -1.856 -399.19%
2007 -3.239 42.7%
2008 -4.352 25.57%
2009 -250 -1640.8%
2010 -528.236 99.95%
2011 -575.469 8.21%
2012 -481.924 -19.41%
2013 -311.299 -54.81%
2014 -888.560 64.97%
2015 -1.259.685 29.46%
2016 -1.962.314 35.81%
2017 -2.791.406 29.7%
2018 -3.762.971 25.82%
2019 -5.514.805 31.77%
2020 -4.809.868 -14.66%
2021 -6.298.959 23.64%
2022 -8.212.154 23.3%
2023 -172.003 -4674.42%

Capex, short for capital expenditures, refers to the money a company spends on acquiring or upgrading tangible assets like buildings, equipment, or technology, which is important for stock investors as it indicates how much a company is investing in its infrastructure to support future growth and profitability.

Sigma Labs, Inc. Capital Expenditure
Year Capital Expenditure Growth
2001 0
2002 0 0%
2003 0 0%
2004 0 0%
2005 0 0%
2006 0 0%
2007 0 0%
2008 0 0%
2009 0 0%
2010 0 0%
2011 22.064 100%
2012 21.460 -2.81%
2013 27.157 20.98%
2014 839.610 96.77%
2015 152.575 -450.29%
2016 87.826 -73.72%
2017 140.460 37.47%
2018 228.525 38.54%
2019 207.711 -10.02%
2020 298.859 30.5%
2021 359.750 16.93%
2022 388.962 7.51%
2023 40.392 -862.97%

Balance Sheet

Balance sheets provide a snapshot of a company's financial health and its assets (such as cash, inventory, and property) and liabilities (like debts and obligations) at a specific point in time. For stock investors, balance sheets help assess the company's overall worth and evaluate its ability to meet financial obligations and support future growth.

Equity refers to the ownership interest or stake that shareholders have in a company, representing their claim on its assets and earnings after all debts and liabilities are paid.

Sigma Labs, Inc. Equity
Year Equity Growth
2001 486
2002 464 -4.74%
2003 -577 180.42%
2004 -81 -612.35%
2005 -6.273 98.71%
2006 -12.590 50.17%
2007 -15.986 21.24%
2008 -23.628 32.34%
2009 -27.012 12.53%
2010 430.358 106.28%
2011 1.101.494 60.93%
2012 557.770 -97.48%
2013 1.280.312 56.43%
2014 3.805.991 66.36%
2015 2.677.348 -42.16%
2016 977.038 -174.03%
2017 2.938.916 66.76%
2018 1.735.439 -69.35%
2019 652.249 -166.07%
2020 5.163.732 87.37%
2021 12.859.751 59.85%
2022 5.074.710 -153.41%
2023 1.974.054 -157.07%

Assets represent the valuable resources that a company owns, such as cash, inventory, property, and equipment, and understanding a company's assets helps investors assess its value and potential for generating future profits.

Sigma Labs, Inc. Assets
Year Assets Growth
2001 2.127
2002 2.090 -1.77%
2003 2.040 -2.45%
2004 4.010 49.13%
2005 4.745 15.49%
2006 2.889 -64.24%
2007 2.422 -19.28%
2008 298 -712.75%
2009 48 -520.83%
2010 475.354 99.99%
2011 1.276.196 62.75%
2012 691.712 -84.5%
2013 1.421.473 51.34%
2014 4.160.341 65.83%
2015 2.787.264 -49.26%
2016 1.869.369 -49.1%
2017 3.394.810 44.93%
2018 2.431.258 -39.63%
2019 1.691.468 -43.74%
2020 5.700.510 70.33%
2021 13.840.990 58.81%
2022 5.703.908 -142.66%
2023 2.837.654 -101.01%

Liabilities refer to the financial obligations or debts that a company owes to creditors or external parties, and understanding a company's liabilities is important for investors as it helps assess the company's financial risk and ability to meet its obligations.

Sigma Labs, Inc. Liabilities
Year Liabilities Growth
2001 1.641
2002 1.626 -0.92%
2003 2.617 37.87%
2004 4.091 36.03%
2005 11.018 62.87%
2006 15.479 28.82%
2007 18.408 15.91%
2008 23.926 23.06%
2009 27.060 11.58%
2010 44.996 39.86%
2011 174.702 74.24%
2012 133.942 -30.43%
2013 141.161 5.11%
2014 354.350 60.16%
2015 109.916 -222.38%
2016 892.331 87.68%
2017 455.894 -95.73%
2018 695.819 34.48%
2019 1.039.219 33.04%
2020 536.778 -93.6%
2021 981.239 45.3%
2022 629.198 -55.95%
2023 863.600 27.14%

Sigma Labs, Inc. Financial Ratio (TTM)

Valuation Metrics

Revenue per Share
0.93
Net Income per Share
-10.44
Price to Earning Ratio
-0.4x
Price To Sales Ratio
7.43x
POCF Ratio
-0.53
PFCF Ratio
-0.83
Price to Book Ratio
1.18
EV to Sales
6.37
EV Over EBITDA
-0.58
EV to Operating CashFlow
-0.75
EV to FreeCashFlow
-0.71
Earnings Yield
-2.52
FreeCashFlow Yield
-1.21
Market Cap
0,00 Bil.
Enterprise Value
0,00 Bil.
Graham Number
28.77
Graham NetNet
0.22

Income Statement Metrics

Net Income per Share
-10.44
Income Quality
0.75
ROE
-1.8
Return On Assets
-0.77
Return On Capital Employed
-1.12
Net Income per EBT
1
EBT Per Ebit
0.99
Ebit per Revenue
-9.22
Effective Tax Rate
-0.02

Margins

Sales, General, & Administrative to Revenue
8.94
Research & Developement to Revenue
0.85
Stock Based Compensation to Revenue
1.27
Gross Profit Margin
0.11
Operating Profit Margin
-9.22
Pretax Profit Margin
-9.12
Net Profit Margin
-9.12

Dividends

Dividend Yield
0
Dividend Yield %
0
Payout Ratio
0
Dividend Per Share
0

Operating Metrics

Operating Cashflow per Share
-7.88
Free CashFlow per Share
-8.37
Capex to Operating CashFlow
0.06
Capex to Revenue
-0.53
Capex to Depreciation
-2.69
Return on Invested Capital
-3.01
Return on Tangible Assets
-3.68
Days Sales Outstanding
41.19
Days Payables Outstanding
707.36
Days of Inventory on Hand
902.9
Receivables Turnover
8.86
Payables Turnover
0.52
Inventory Turnover
0.4
Capex per Share
-0.49

Balance Sheet

Cash per Share
0,99
Book Value per Share
3,52
Tangible Book Value per Share
1.3
Shareholders Equity per Share
3.52
Interest Debt per Share
0.02
Debt to Equity
0
Debt to Assets
0
Net Debt to EBITDA
0.1
Current Ratio
1.65
Tangible Asset Value
0,00 Bil.
Net Current Asset Value
0,00 Bil.
Invested Capital
0
Working Capital
0,00 Bil.
Intangibles to Total Assets
0.44
Average Receivables
0,00 Bil.
Average Payables
0,00 Bil.
Average Inventory
857550
Debt to Market Cap
0

Dividends

Dividends in stock investing are like rewards that companies give to their shareholders. They are a portion of the company's profits distributed to investors, typically in the form of cash payments, as a way for them to share in the company's success.

Sigma Labs, Inc. Dividends
Year Dividends Growth

Sigma Labs, Inc. Profile

About Sigma Labs, Inc.

Sigma Labs, Inc., a software company, provides in-process quality assurance software to the additive manufacturing industry. It offers PrintRite3D, an integrated hardware and software edge computing platform that combines inspection, feedback, data collection, and critical analysis. The company also provides PrintRite3D Direct Energy Deposition for metal parts and PrintRite3D Selective Laser Sintering, for polymer materials. It serves aerospace, defense, oil and gas, bio-medical, and power generation industries. The company was formerly known as Framewaves Inc. and changed its name to Sigma Labs, Inc. in September 2010. Sigma Labs, Inc. was incorporated in 1985 and is headquartered in Santa Fe, New Mexico.

CEO
Mr. John Rice
Employee
33
Address
3900 Paseo Del Sol
Santa Fe, 87507

Sigma Labs, Inc. Executives & BODs

Sigma Labs, Inc. Executives & BODs
# Name Age

Sigma Labs, Inc. Competitors